{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-038506","form_type":"8-K","ticker":"CGON","cik":"0001991792","company_name":"CG Oncology, Inc.","filed_at":"2024-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.419690+00:00","generated_at":"2026-06-06T00:28:08.731100+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"CG Oncology discloses 2023 executive bonuses in amended summary comp table","bullets":["CEO Arthur Kuan awarded $189,000 performance bonus for 2023; total comp $3.93M.","COO Ambaw Bellete received $189,500 sign-on bonus plus $179,740 performance bonus; total $3.03M.","CMO Vijay Kasturi received $56,000 sign-on bonus plus $87,448 performance bonus; total $2.44M.","Bonuses omitted from Jan 2024 IPO prospectus; now reported in Item 5.02 filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-038506","json":"https://secwatch.observer/filing/0001193125-24-038506.json","markdown":"https://secwatch.observer/filing/0001193125-24-038506.md","text":"https://secwatch.observer/filing/0001193125-24-038506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1991792/000119312524038506/0001193125-24-038506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1991792/000119312524038506/d773011d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T00:28:08.731100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}